2022 Full Event Guide
View the Entire Speaker Faculty, Session Details, Partner Information, Pricing & Discounts
Having trouble downloading the brochure? Let us know and we’ll email it to you instead
Top 5 Reasons to Attend:
- Decipher the intricate mechanisms underlying dysregulated inflammasome signaling within the wider context of the immune system
- Overcome limitations of preclinical models, identifying clinically meaningful biomarkers of inflammasome inhibition, and defining good clinical endpoints
- Tame inflammation and achieving optimized safety profiles using the next frontier for inflammasome-targeted drugs including those targeting NLRP3 and novel targets
- Delve into specific disease groups to demonstrate where inflammasome therapeutics will be most impactful